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Abstract 
The purpose of this project was to develop a practice guideline for screening patients at 
risk for cardiovascular disease, educate the staff at the site about the guideline, and 
implement the guideline at a primary care clinic. The intention was to identify and treat 
patients at risk for cardiovascular disease to prevent occurrence of heart disease. 
Cardiovascular disease includes hypertension, coronary heart disease, heart failure, and 
stroke. Coronary heart disease is one of the leading causes of death in the Western world. 
The local practice problem and focus of this project was underprescribed statin therapy 
for patients at risk for developing heart disease at a clinic in the southern United States. 
The practice-focused question that guided this project explored whether an evidence-
based clinical guideline that might impact the prescription of statins for the prevention of 
cardiovascular disease would be approved for implementation in a primary care clinic 
serving adult and geriatric patients. The appraisal of guidelines for research and 
evaluation and the Fineout-Overholt model were used to guide this project. Sources of 
evidence to meet the purpose of this project were obtained from the literature and 
scholarly articles. After the guideline presentation to the expert panel they agreed to 
implement the clinical practice guideline at the project site and agreed to track the results 
in a quality improvement initiative. The implications of this project for positive social 
change might include improved management of patients who are at risk for heart disease 
and a decrease in premature deaths related to cardiovascular disease. 
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Section 1: Nature of the Project 
Introduction 
Coronary artery disease (CAD) is the leading cause of death in the United States 
and is responsible for one out of three deaths in the United States (American Heart 
Association [AHA], 2017). CAD is the buildup of plaque in the arteries of the heart, 
which restricts the necessary blood flow to the heart (Gander et al., 2014). This then 
causes a lack of oxygen rich blood to the heart muscles, which then leads to ischemia of 
the heart tissue and ultimately significant damage, a myocardial infarction (Lubna, 2014). 
Risk factors for CAD can be divided into two categories: modifiable and 
nonmodifiable/conventional (Pencina et al., 2019). Modifiable risk factors are (a) high 
blood pressure, (b) high blood cholesterol, (c) diabetes, (d) smoking, (e) overweight, and 
(f) unhealthy diet and lack of physical activity (Lubna, 2014). The nonmodifiable risk 
factors include (a) increase of age (geriatrics), (b) gender with men at an increased risk, 
(c) race, and (d) family history (Kannel & Ramachandran, 2009). 
Clinical guidelines are used to follow protocol for the best care method for 
medication delivery (Lawal et al., 2006). A clinical guideline is a tool used to help 
manage the quality in healthcare transactions by focusing on the standardization of a 
specific process (Grimsmo et al., 2018). The nature of this doctoral project was to 
develop and implement a clinical guideline to increase the use of statin therapy to those 
patients who are considered at risk for coronary heart disease.  
In a primary care setting, a clinical guideline can be used to screen and identify 
those at risk for CAD and treat them with statin therapy to help prevent the development 
2 
 
of CAD. The clinical guideline is a tool that should be used to help manage quality in the 
healthcare setting on statin use by focusing on the standardization of the care process 
between the providers and the patient.  
A clinical guideline improves the quality of health and outcomes for patients with 
various diseases (Lawal et al., 2006). In 2012, the Norwegian government’s care 
coordination reform was launched. A clinical guideline was designed for a constant and 
integrated clinical approach that emphasizes primary care services and primary care’s 
role prominently after hospitalization (Lawal et al., 2006). This section contains 
explanation of the problem, purpose, and methodology used for this project.  
Problem Statement 
The practice problem was identified at the primary care clinic that was the subject 
of this doctoral project. At this clinic, 40% of the patient population who present with 
risk factors are not on a statin. This may be due to the fact that patients only come to the 
clinic for sick visits. The nature of the patient population consists of about 60% geriatrics 
and about 45% women. The patients with insurance have well visits for lab work 
covered, but again, that population seems to only come for sick visits.  
CAD is a type of cardiovascular disease along with heart failure and stroke. 
Cardiovascular disease was responsible for 25% of deaths in the United States in 2013 
(Short, Walls, Smith, & Loustalut, 2014). The use of statins to reduce LDL levels has 
long been accepted as an important preventive measure to delay or even prevent the onset 
of cardiovascular disease (Yusuf et al., 2016). However, many primary care practices do 
not routinely evaluate patients for their risk of developing CAD and fail to prescribe this 
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lifesaving class of drugs to their patients. In fact, at the primary care clinic that was the 
subject of this DNP project, over 40% of the current patient population was at risk for 
developing cardiovascular disease, but they had not been assessed for cholesterol levels 
nor had their family history been reviewed. 
Cholesterol has been broken down into two different components: LDL 
cholesterol and HDL cholesterol. The LDL type of cholesterol has been identified as the 
harmful type, while the HDL cholesterol has a protective factor. High levels of LDL 
cholesterol have been shown to predict the onset of CAD. The AHA and American 
College of Cardiology (ACC) patient care guidelines recommend treatment with 
cholesterol-lowering medications in patients at risk for developing CAD (Jones et al., 
2016). Medications known as statins help prevent coronary heart disease by lowering 
LDL cholesterol levels; this has been identified through research as a primary 
precipitating factor in CAD (Jones et al., 2016). The local practice problem that was the 
focus of this doctoral project is the under prescribed use of statin therapy to those patients 
at risk of heart disease for prevention at a clinic in a suburban region of the state of 
Georgia. 
Practice guidelines for statin use in primary care is essential (Yusuf et al., 2016). 
Because many patients at risk for developing CAD appear healthy, they may not 
recognize the need for cholesterol-lowering medications until they are already 
symptomatic, which may be too late (Mcnaughton & Shucksmith 2014). Poor patient 
outcomes may result when there is no clinical guideline in use (Tehrani, Michell, & Pan, 
2018). When a drug is introduced, this is an opportune time to have a clinical guideline in 
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place within the medical institution (Burke et al., 2008). Not having this protocol in place 
is problematic for the nurses and nurse practitioners because the proper treatment path 
may not be clear (Sheppard, Fletcher, McManus, & Mant, 2014). The institution and the 
practitioners are all at risk; they will be held accountable for the outcome of patients 
being cared for there (Johnson, Blasdell, Walker, & Eggleston, 2000). The primary care 
clinic may benefit from having a clinical guideline in place to assure consistent practice 
based on the latest research evidence among the practitioners who practice in that venue. 
In addition, the use of practice guidelines may reduce variation in practice (Panella, 
Marchisio, & Di Stanislao, 2003). The practice problem identified at the facility was the 
underprescription of statin therapy to at-risk patients for prevention of coronary heart 
disease. This was observed by a random review of 10 patient laboratory studies and 
recorded daily medication for VI months compiled by the site staff and provided to me as 
the DNP student. Out of the 10 de-identified patient charts, six patients had increased 
LDL levels, and a further breakdown showed four patients who smoke cigarettes. 
Moreover, some of the patients also had other risk factors, such as obesity and diabetes 
(Panella et al., 2003). In the world at large and at the DNP project site specifically, people 
who present with risk factors for coronary heart disease are not prescribed statin therapy 
as evidenced by previous research performed (Sheppard et al., 2014). 
Purpose 
The purpose of this doctoral project was to develop a standardized clinical 
guideline for primary care facility nurses and practitioners, guiding thee practitioners to 
prescribe statins when indicated to prevent the emergence of heart disease. The gap in 
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practice was that patients who presented with risk factors for developing coronary heart 
disease were not being properly screened and did not receive a prescription for statins in 
this primary care setting. The risk factors included high blood pressure, high blood 
cholesterol, diabetes and prediabetes, smoking, being overweight or obese, being 
physically inactive, having a family history of early heart disease, having a history of 
unhealthy diet, and women age 55 or older (Panella et al., 2003). Gamboa et al. (2014) 
studied 30,239 people, all age 45 or older, in a REGARDS research program who were at 
high risk for developing coronary heart disease and determined that many of the 
participants did not receive a statin. Meid et al. (2015) reiterated that cardiovascular 
disease is a leading cause of death among the elder patient population. Gamboa et al. 
(2014) also pointed out that important medications to help prevent heart disease are often 
underutilized and suggested a prescribing criterion be developed for those patients at risk 
for heart disease. 
Plans for implementation were included in this project. The guiding practice-
focused question for this doctoral project was: In a primary care clinic serving adult and 
geriatric patients, will an evidence-based clinical guideline that can potentially impact the 
prescription of statins for the prevention of cardiovascular disease be approved for 
implementation?  
Nature of the Doctoral Project 
Current guidelines that have been established and utilized provided the basis for 
the practice guideline developed for practitioners at the DNP site, as guidelines have been 
developed specifically for primary care (Panella et al., 2003). The sources of evidence 
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collected to meet the purpose of this doctoral project were obtained from literature and 
scholarly articles. Online database searches were also used to narrow down the dates of 
the articles reviewed. Keywords included coronary heart disease, CAD, statins, LDL, 
statins, and heart prevention in primary care. The dates searched were 2014–2019. Other 
sources included the latest ACC and AHA guidelines for statin therapy in prevention of 
coronary heart disease. Other sources that were reviewed were medications and labs of 
unidentified patients, which assisted in identifying the practice problem. 
I implemented a literature review of scholarly articles for relevant evidence. 
Reviewing the literature on coronary heart disease and how prevention can play a key 
role in avoiding cardiac-related deaths assisted in formulating a clinical guideline to 
standardize the care provided to help prevent heart disease. I analyzed the literature for 
evidence-based recommendations that supported the clinical guideline.  
I assembled a team of experts, including nurse practitioners and other primary 
care providers at the DNP project site, to provide feedback regarding the planning phase 
in the development of the practice guideline. We discussed the plan and I allowed for 
feedback from the team to review other possible strategies to guarantee this pathway’s 
success. Thereafter, a revision occurred during a meeting before I finalized the pathway. 
Staff education on the use of a practice guideline in the practice arena was held. Staff 
members were also educated on the importance of scheduling well visits for patients, 
checking labs with specific attention to cholesterol levels, and setting a two-week follow 
up appointment with the patient to review their lab results. This project included the 
development and education of clinical guidelines for the staff. However, full 
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implementation of the guidelines and evaluation of its impact on statin use at the site is 
beyond the scope of this DNP project. Nonetheless, involving the expert team at the site 
in the development and education regarding the guideline will ensure its ultimate success 
in increasing statin use at the primary care site.  
Significance of the Project 
The stakeholders involved were the primary care providers, nurse practitioners, 
clinical office manager, and medical assistants who work at the practice and the patients. 
This practice guideline doctoral project is important to nursing practice because it helped 
standardize care in a primary care facility, which in turn may prevent deaths related to 
heart disease. The clinical guideline developed in this DNP project will be used in the 
primary care setting that is the site for the DNP project to screen individuals at risk and to 
begin statin therapy to prevent cardiovascular disease. The benefits for the use of the 
statin therapy practice guideline extends to other settings in addition to the primary care 
practice that is the setting for the project. Other primary care practices, including nurse-
run clinics, hospital-based outpatient clinics, and private practices can benefit from the 
practice guideline developed for this DNP project.  
The implication for positive social change was for patients who are at risk for 
heart disease to be identified, better manage their health, have a positive outlook of life, 
resulting in an increased quality of life, and minimizing the chances of premature deaths 
related to cardiovascular disease. Clinical guidelines lessen costs and advance quality by 
decreasing errors, refining synchronization among interdisciplinary team members, 
restructuring case management tasks, delivering methodical records for evaluating care, 
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and decreasing discrepancy in practice designs (Panella et al., 2003). Research has shown 
that settings that executed clinical guidelines in practice have shown positive patient 
outcomes (Jones-Lloyd et al., 2017). 
Summary 
CAD is a type of cardiovascular disease along with heart failure and stroke. 
Cardiovascular disease was responsible for 25% of deaths in the United States in 2013 
(Short et al., 2014). Stone et al. (2014) recommended treatment with cholesterol-lowering 
medications called statins to help prevent CAD. At the primary care clinic that is the 
subject of this DNP project, over 40% of the current patient population at risk for 
developing cardiovascular disease have not been assessed for cholesterol levels, nor has 
their family history been reviewed. Thus, this gap in practice leaves several patients at 
risk for developing cardiovascular disease because statin use was not consistently being 
prescribed there.  
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Section 2: Background and Context 
Introduction 
When there is no clinical guideline, nurses must deal with poor patient outcomes 
(Tehrani, Michell, & Pan, 2018). The purpose of this project was to develop a clinical 
guideline for the primary care site that would create standardization for increased 
prescription use of statin therapy for those individuals at risk for CAD. This DNP project 
closed the gap between the available evidence-based guideline, literature, and current 
practice of managing the sick visit only and not attending to the patient as whole, 
evaluating their risk for CAD, and prescribing a statin. In the following section, I will 
discuss the model used to guide the development of this practice guidelines project, the 
relevance of the project to nursing practice, background, and context as well as 
information about me, the DNP student. 
Concept, Models and Theories 
Statin Use as a Preventive Measure 
Pharmacotherapy for blood pressure and cholesterol lowering are both successful 
at decreasing cardiovascular risk, and evidence-based guidelines suggest the use of statins 
in people who have high risk for cardiovascular events (Sheppard et al., 2015). Underuse 
of cardiovascular disease (CVD) deterrence medication is frequent in healthcare systems 
all over Europe and North America (Sheppard et al., 2015). The Framingham Heart Study 
showed that there is a lethal connection between blood-cholesterol LDL-C levels and 
CVD (Framingham Heart Study, 2019). LDL-C is the primary lipid-carrier protein, and a 
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buildup of LDL in the blood will affect oxidation and form plaque that will lead to 
atherosclerosis (Lubna, 2014).  
Chou et al. (2016) studied the benefits of the use of statins to prevent heart disease 
using meta-analysis to summarize multiple randomized clinical trials. The meta-analysis 
compiled various comparisons: (a) statins versus placebo, (b) fixed dose versus titrated 
statins, and (c) higher versus lower intensity statins in adults without a history of 
cardiovascular events (Chou et al., 2016). The target population consisted of adults 40 
years and older with no prior history of having a cardiovascular event (Chou et al., 2016). 
Meta-analysis was used to calculate the risk ratios; the trials included had between 95 and 
17,802 participants (Chou, et al., 2016). The researchers found that in adults with high 
risk for CVD, but with no prior coronary event, statin therapy reduced those individual 
risk factors and CVD mortality along with coronary events (Chou et al., 2016).  
The U.S. Preventative Services Task Force (USPSTF, 2016) recommends that 
individuals with no known history of CVD and who are between the ages of 40 to 75 
with one or more risk factor be started on a low-dose statin, or 80 mg of aspirin, to 
prevent mortality and coronary events. Statins have demonstrated a medical advantage 
for the primary prevention of CVD events in adults (USPSTF, 2016).  
Statin Use: When It Is Needed and When It Is Not  
The USPSTF (2016) proposes starting the use of low- to moderate-dose statins in 
people 40 to 75 years who do not have a history of CVD or have one or more CVD risk 
factors and a determined 10-year CVD event risk of 10% or more. The USPSTF (2016) 
also determined that the existing substantiation of evidence is not enough to recommend 
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the benefit and problems associated with starting statin use in adults 76 years and older. 
Although there is a tremendous amount of evidence on the benefits of statin therapy, use 
of statins in the elderly population (age 76 or older) needs to be analyzed thoroughly 
(Pedro-Bolet et al., 2015). Quality of life as well as adverse effects that may occur in this 
age group involving statin drugs should be considered when prescribing decisions are 
made for this population (Pedro-Bolet et al., 2015).  
Healthy Heart Strategies 
Cardiovascular disease consists of a class of conditions including, but not limited 
to, heart failure and stroke (Go et al., 2014). About 78 million adults suffer from 
hypertension in the United States; hypertension is considered a modifiable risk factor (Go 
et al., 2014). Maintaining a normal blood pressure is needed to reduce occurrence of 
CVD-related events (Go et al., 2014).  
Obesity, poor diet, and decreased physical activity are also modifiable risk factors 
(LeFevre, 2014). Improving nutritional intake and healthy eating habits as well as an 
increase in physical activity all help prevent CVD (LeFevre, 2014). There are more 
strategies that individuals can implement to improve their odds of staying healthy and 
avoiding CVD. For example, LeFevre (2014) discussed behavioral counseling as an 
intervention and evaluated counseling that involved physical activity, tobacco cessation, 
and a healthy diet and its impact on CVD. Counseling interventions were reviewed for 
the modification for a healthy diet and physical activities (LeFevre, 2014). The 
population consisted of adults who were 18 years and older in the primary care arena who 
were overweight/obese with cardiovascular risk factors. In this systematic review, there 
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were 74 trials with a total of 77 intervention groups, and evidence pointed to the 
efficiency of behavioral counseling (LeFevre, 2014). Among participants, the total 
cholesterol levels were lowered to about 0.08 to 0.16 mmol/L with the LDL being 
decreased by about 0.004 to 0.13 mmol/L (LeFevre, 2014). Behavioral counseling helps 
those individuals at risk change habits to live a healthier lifestyle (LeFevre, 2014).  
Rosswurm and Larrabee’s Model 
Rosswurm and Larrabee (1999) developed knowledge of practice-based model 
studies associated with an evidence-based practice. Their model directed the 
transformation of evidence-based practice guidelines into practice by adapting the 
suggested guidelines to different practice settings (Gawlinski & Rutledge, 2008). This 
model endorses a methodical process for taking research, the highest form of evidence, 
and integrating findings into practice (Gawlinski & Rutledge, 2008). 
Rosswurm and Larrabee’s (1999) model lays out a plan for incorporating 
research-based practices that will work well in various settings and support stakeholders. 
There are six stages to this model: (a) assess, (b) link, (c) synthesize, (d) design, (e) 
implement/evaluate and (f) integrate/maintain (Rosswurm & Larrabee, 1999). The first 
stage encompasses assessing the necessity for transformation in practice. This will 
include the stakeholders in the development of equating core facts with other findings to 
detect the problem. The next stage relates the identified problem, intercession, and results 
to make sure the habit of uniformity of systems and language are being used. The third 
stage involves the use of blending paramount evidence by studying literature associated 
to the key variable. The next stage schemes a recommended modification in practice, 
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recognizes necessary materials, strategizes the carrying out process, and describes the 
projected results. In the penultimate stage, implementation and evaluation of the change 
are performed in a pilot study; this is where the decision to adopt the practice change is 
made. The final stage assimilates and preserves the practice change by informing the 
suggested practice change to stakeholders by having in-services on the practice change 
and incorporating the change into practice and continuous observation of the course and 
results (Rosswurm & Larrabee, 1999). Using this model will help provide guidance to the 
nurses and other medical professionals to the practice by using systematic steps to 
enforce the change to the practice. Although this project will not include implementation, 
this model will help stakeholders in the future for implementation purposes.  
Appraisal of Guidelines for Research and Evaluation II and Fineout-Overholt 
The appraisal of guidelines for research and evaluation (AGREE II) is a 
framework used to help advance reporting of clinical practice guidelines (Brouwers et al., 
2010). AGREE II was developed to tackle the problem of inconsistency in guideline 
quality (Brouwers et al., 2010). I used AGREE II in this doctoral project by applying it to 
the proposed guideline before its application into the practice. It allowed for a 
methodological development of the proposed guideline and provided room for 
stakeholders’ evaluation of the guideline.  
The Fineout-Overholt concept was also used for this project. This concept was 
applied to analyze the quality of evidence obtained and to rank the evidence level. 
Ranking of the evidence level will be from I to VII (see Appendix A). This ranking 
process helped strengthen the reliability of the guideline being proposed. The literature 
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matrix showed how this clinical guideline aligns with the most recent research evidence, 
thereby enabling evidence-based practice. Note that in Appendix A, all evidence 
provided for the clinical guideline ranks from I to VII with the level of evidence 
provided, indicating that the practice guideline is supported by the research evidence. 
Relevance to Nursing Practice 
In the history of nursing practice, physicians will write prescriptions or plan of 
care based on intellectual knowledge (Reuter & Fitzsimons, 2013). This may have caused 
the underuse of prescriptions employed for preventive care and management (Reuter & 
Fitzsimons, 2013). Physicians had to manually write a patient’s plan of care in order for 
nurses to carry out the orders (Reuter & Fitzsimons, 2013). In 1893, Lillian Wald, was a 
graduate nurse from New York Training School. She started the Henry Street Settlement 
in Manhattan (Keeling, 2015). Initially she and her colleagues started making nursing 
rounds to the poor as well as making necessary referrals to physicians (Keeling, 2015). 
The demand for nurses increased, and by 1990, 12 more nurses were hired to carry out 
physician prescribed medicines (Keeling 2015). With the advent of advanced practice 
licensure for registered nurses, this dynamic has changed considerably.  
Gurzick and Kesten (2010) propose that compliance with the use of care pathways 
is below average. The authors suggest that the use of clinical guidelines will help 
improve patient outcomes and reduce healthcare cost all while ensuring that evidence-
based practice is being followed in the healthcare setting (Gurzic & Kesten, 2010). In 
summary, Gurzick and Kesten (2010) have revealed that there is a need for clinical 
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guidelines to help ensure that evidence-based practice is being used in the healthcare 
setting. 
Quinn (2017) reviewed case studies and analyzed several cases which showed 
that primary care providers were responsible for the misdiagnosis of cardiovascular 
disease by not properly screening the patient for heart disease. A clinical guideline can 
aid in the increase use of statin therapy to prevent heart disease. Likewise, Muller et al.’s 
(2009) study revealed that in the post-operative unit in the hospital being studied a 
clinical guideline reduced hospital stay by 28% and decreased nursing hours. 
Nurses for many years have been managing risk factors (hypertension, smoking, 
diabetes) to prevent coronary heart disease. Some of the ways this is done is by the use of 
programs/guidelines in primary care (Hayman, et al., 2015).  The advanced practice nurse 
practitioner with prescriptive authority (APRN/NP) holds a primary role in disease 
prevention (Thomas, Hart & Burman, 2014).  Nurses can help reduce the risk factors 
involved with coronary heart disease by following the treatment guidelines. 
Local Background and Context 
The intended practice setting for this doctoral project was an outpatient primary 
care setting in Georgia. The practice setting is a primary care office. Close to 60% of the 
patients are 55 years and older; 45% of the total population are women. This project will 
help improve patient care outcomes for those with moderate to high risk of developing 
coronary heart disease at the practice facility. Currently a policy is in place for statin 
therapy use for those at risk which is not being carried out. This may be due to the 
practitioners focusing more on the acute reason of the patients visit and not on 
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prevention. Therefore, a training tool was provided for staff as well as a plan for 
implementation. Rosswurm and Larrabee’s model will help assist in the change in order 
to implement the clinical guidelines and all its components for their go live date. Primary 
care practice is often dictated by habit and “the way we have always done things,” so 
incorporating a change based on the latest research evidence may require specific tools, 
including a practice guideline. In addition, the patients who visit the primary care practice 
that is the subject of the DNP project often do so for acute care needs. They come to the 
practice for symptoms of the flu, or an upper respiratory infection. The providers in the 
practice focus on the need at hand, and the day to day management of chronic illnesses 
rather than on prevention.  
There were four people who served as members of the expert panel. The panel 
consisted of three nurse practitioners and one physician all in the primary care practice 
setting. The two medical facility sees roughly about an average of 25 to 30 patients a day 
with most patients coming in for acute problems not related to their preventive care 
needs. The practice guideline with accompanying support materials will potentially 
change what the nurse practitioners and doctors do with patients in the interest of 
prevention after full implementation which will occur outside of the DNP project’s scope. 
The medical assistants were also trained to print out the patient’s last lab results and to 
attach these to the clipboard with the chief complaint. This allows the nurse practitioners 
and the physicians to have the patient’s lab work results at hand as well as the guideline 
in the exam room to be able to implement the practice guidelines. If no recent labs are 
available, the medical assistant should write boldly no recent labs. To ensure that the 
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proposed practice guidelines be used, a recommendation for quarterly chart audits was 
made. The decision for chart audits is solely dependent on the key stakeholders and 
members of the expert panel who will be reviewing the guideline for use in the practice.  
According to the Georgia Department of Health (2016), cardiovascular disease is 
the leading cause of deaths for the state. In 2008, coronary heart disease attributed to 179 
deaths in the state of Georgia (Georgia Department of Health, 2016). Almost half of the 
population in Georgia from 2009-2010 has had high cholesterol levels. This is the reason 
this topic should be examined more closely in Georgia. Having the opportunity to 
conduct the DNP project at this setting will help to educate the nursing staff regarding the 
importance of the initiation of statin therapy and lifestyle modifications which can reduce 
patients’ chances of developing heart disease. Some lifestyle modifications consist of 
maintaining a healthy diet and staying physically active. 
Definitions of Terms 
Clinical practice guidelines: A tool that is used to help manage the quality in 
healthcare transactions by focusing on the standardization of a specific care process 
(Lawal et al., 2016).  
Cardiovascular disease: Includes hypertension, coronary heart disease, heart 
failure and stroke (Centers for Disease Control and Prevention [CDC], 2014). 
Statins: Cholesterol lowering class of medications (CDC, 2014). 
Role of the DNP Student 
Leadership is an essential skill that is needed in order for the clinical guideline to 
be effective. A doctoral student should possess strong leadership skills in order to 
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persuade the stakeholders at the site. Change in an organization is not always embraced 
by staff. Currently I take on the role as a primary care provider expert in an outpatient 
center. My motivation for this doctoral project is that I have had a loved-one die from 
cardiovascular disease within months after the birth of her last child. Her death occurred 
in the ’90s and since that time healthcare has been much improved. 
Anecdotally, staff members at the clinic report that preventive measures for 
chronic illness have not been a priority, and that there are many opportunities to focus on 
preventive care even though the primary reason for presentation is for an acute episode of 
illness. A clinical guideline to increase the prescription use of statin therapy would go a 
long way to changing practice at the site. I served as project leader for the development 
of the practice guideline and sought support from the staff during this process. A 
thorough and comprehensive literature review starting with main sources of evidence 
such as original research findings and systematic reviews was conducted and presented. I 
developed the clinical guideline and presented it to the staff for discussion, provided an 
adjusted workflow that assured implementation and readied a package for the expert 
panel to approve. I used the Rosswurm and Larrabee’s conceptual framework and the 
Agree II, Grade models for the development of the practice guideline. Using these 
conceptual framework models, stakeholder contribution is considered, plus the patient, 
the practice providers and the practice structure.  
Summary 
Literature was presented that supports the use of clinical guideline to improve the 
prescription use of statin therapy to prevent cardiovascular disease. Implementing the use 
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of care pathway is a solution to increase statin therapy for cardiovascular disease 
prevention. Thus, filling the gap between the evidence-based guidelines and the current 
practice of no clinical guideline. This portion of this project focused on the theoretical 
concepts needed to close the gap in current practice. The next segment of the project will 
re-visit the problem-focused question and review evidence needed and generated for the 
development of the project. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
The purpose of this practice guideline project was to develop a standardized 
clinical guideline for the primary care facility nurses and practitioners, specifically 
around the prescription of statins as it relates to heart disease. To advance positive social 
change, the initiation of statin therapy for those at risk needs to be addressed with 
evidence-based strategies and interventions. Presently, at the DNP project setting, most 
patients come to the primary care practice for minor acute illness; preventive care is not 
often a priority. Consequently, patients at risk for CVD often are not prescribed statin 
therapy, nor are they advised on lifestyle modifications that can also be effective in 
preventing CVD. This project was developed to decrease the incidence of heart disease to 
those at risk. The goal of this pathway is to increase the prescription use of statins at the 
primary care facility for those patients at risk for heart disease. When implemented by the 
organization, the new evidence-based clinical guideline will address the clinical practice 
gap to initiate statin therapy for those individuals at risk. In the next segment of the 
project, the practice question will be reviewed along with sources of evidence collected 
and used. 
Practice Focused Question 
In the primary care setting, implementation of a clinical guideline is useful to 
assist clinical personnel in the primary care setting, such as physicians and nurses for 
patient care (Grimsmo et al., 2018). Presently, as most patients come to the clinic for an 
acute episode of minor illness, like upper respiratory infections, attention to preventive 
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care of any kind is not embedded in the practice. This represents the most prominent gap 
in practice. The practice guideline presents a systematic way for treatment decisions in 
the primary care facility that may increase the prescription of statin drugs to help prevent 
heart disease.  
The practice-focused question guiding this project is as follows: In a primary care 
clinic serving adult and geriatric patients, will an evidence-based clinical guideline that 
can potentially impact the prescription of statins for the prevention of cardiovascular 
disease be approved for implementation? Full implementation and evaluation of this 
clinical guideline is the responsibility of the stakeholders at the practice site. The clinical 
guideline will serve as a guide for the organization. The goal of this clinical guideline is 
to identify those at risk for coronary heart disease and to initiate statin therapy for 
prevention purposes. 
Sources of Evidence 
Published Outcomes and Research 
Clinical guidelines are useful in improving patient outcomes when practice is 
based on sound evidence (Williams & Radnor, 2017). Sources of evidence for this 
practice guideline project consist primarily of literature that summarizes the positive 
effects of the use of statins in primary care. CINAHL and Medline databases were 
searched. Key terms used for the literature search were coronary heart disease, 
cardiovascular disease, heart disease, prevention of heart disease, statin therapy, statin 
indications and contraindications, and additional strategies needed. The collection of 
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evidence was facilitated by accessing scholarly journals, Georgia Department of Health 
and the CDC website. The initial search period was between the years 2002 and 2018.  
Evidence Generated for the Doctoral Project 
Participants. There were three nurse practitioners (NPs) and one internal 
medicine physician working in the primary care clinic that was the setting for this DNP 
project, which has two different geographic locations. As clinical practitioners, their 
activities are directly related to the implementation of the guideline in terms of 
diagnosing and prescribing medications. The physician is the owner of the practice, and 
as such, sets the tone for decision-making at the practice. The three NPs do have some 
autonomy in the practice and serve as licensed advanced nurse practitioners with 
prescriptive rights (APRN/NPs). Their input, review and evaluation of the practice 
guideline are necessary as they will address the practicalities of implementation.  
Procedures. The evidence-based clinical guideline was presented to a panel of 
experts to provide feedback that meets criteria in their expert opinion. I provided 
education on the use of the clinical guideline using a PowerPoint to provide an overview 
of the guideline for the expert panel. The clinical practice guideline with its 
accompanying algorithm for managing statin use is found below in Figure 1. Also, a tip 
sheet with a single page of instructions can be found in Appendix B.  
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Figure 1. Statin clinical practice guideline for practice use. 
There were three two-hour sessions held at each of the two primary care locations 
to review the details, the revised workflow, algorithm, and clinical guideline being 
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implemented. The three sessions were the same. This guaranteed that all staff who are 
required to attend had the opportunity to do so. Education on the clinical guideline was 
provided. Each clinical staff member was given a copy of the manual and the clinical 
guideline. Time was allowed for questions and discussion during the presentation of the 
clinical guideline. Within the DNP project, meetings were held with the nursing staff to 
define the process for the use of a clinical guideline to increase the prescription use of 
statin drugs to those patients at risk for heart disease.  
The involvement of the expert committee was crucial for the development of the 
clinical guideline. The participants who were selected were invited by personal request to 
participate in the review process. There were four panel members who are experts in 
primary care with a total of over four years of experience in the practice setting.  
Protections. The Walden IRB manual for a practice guideline DNP project was 
followed. The medical director at the site had verbally expressed a commitment to the 
project and signed the consent. The site does not have an IRB therefore the project was 
deferred to Walden IRB for protection of human subjects, approval number 06-19-19-
0553962. 
Analysis and Synthesis 
According to Mengual-Andrés, S et al. (2016), the Delphi method has been used 
for various projects. It assists in the use of expert opinions for different program planning 
projects. This was applied to the final clinical guideline. This method allowed for 
feedback as necessary to assure the ultimate success of the guideline in shaping 
preventive care at the practice. This method allowed for expert feedback on their 
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willingness to proceed to full implementation. The clinical guideline provided a step by 
step process on the implementation of statin therapy at the primary care facility. 
The Delphi method was used to achieve consensus, increase communication to 
accomplish certain goals or policy development. The Delphi process consisted of 
different rounds. In round one open ended questions were used to gather the information 
(see Appendix D). Round two included additional open-ended questions as well as 
feedback from round one. The purpose of the questions in the first two rounds was to 
elicit any needed revisions, or any anticipated barriers to implementation. By the time of 
round three consensus from the panelists regarding their full support for use of the 
practice guideline to improve preventive care, in this case, statin therapy for the at-risk 
individuals was achieved. Rationale on why a clinical guideline in place would be 
beneficial on the implementation on statin therapy to the at-risk individuals to prevent 
coronary heart disease was reviewed. The last round, round three, summarized the 
opinions by the expert panel. The practice guideline for statin therapy implementation 
was then validated with plans for implementation defined.  
Summary 
The DNP project proposed is to develop a standardized practice guideline to 
increase the prescription use of statin therapy for those at risk for heart disease. The 
practice guideline was developed and presented to an expert panel for their review and 
consensus, approving the guideline for full implementation at the practice. Section 4 will 
provide the results of the DNP project.  
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Section 4: Findings and Recommendations 
Introduction 
The purpose of this doctoral project was to develop a standardized clinical 
guideline for primary care facility nurses, practitioners, and physicians, guiding them to 
prescribe statins when indicated to prevent the emergence of heart disease. The practice-
focused question that guided this project was: In the primary care clinic serving adults 
and geriatric patients, will an evidence-based clinical guideline impact the prescription of 
statins for the prevention of cardiovascular disease be approved for implementation? Full 
implementation and evaluation of this clinical guideline is the responsibility of the 
stakeholders at the practice site. The local gap in practice was that patients come to the 
clinic for primarily for acute issues and attention to preventive care of any kind was not 
embedded in the practice.  
Findings and Implications 
There were three nurse practitioners all who have been nurse practitioners for a 
minimum of 4 years and a physician with over 10 years of experience who participated as 
members of an expert panel. There are two primary care clinics in the practice, both 
located in the inner city of a metropolitan Georgia area. The three nurse practitioners do 
have some autonomy in the practice with prescriptive rights. At both primary care clinics, 
40% of the current patient population had presented with risk factors for heart disease but 
had not been prescribed a statin. A further breakdown showed that 60% of that number 
were geriatrics and 45% were women.  
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Underprescription of statins for patients at risk for heart disease remains a 
problem at this site’s clinic. Underprescription of statins for patients who present with 
risk factors may lead to an increased number of patients who develop heart disease. This 
doctoral project allowed for the issue of underprescription of statins to be analyzed in a 
primary care setting and for nursing interventions to be implemented to address this gap 
in practice.  
Cardiovascular disease is a leading cause of death among the elderly patient 
population (Meid et al., 2015). The basis of this doctoral project was for the use of a 
clinical practice guideline to address the underprescription of statins to at-risk patients. 
This project was developed as a clinical practice guideline to increase health literacy for 
nurses, practitioners, and physicians.  
During the three sessions, an in-depth review of the practice guideline was 
provided. In addition, feedback from the expert panel was secured. All four providers 
agreed that the clinical practice guideline represents recent research evidence and was 
well-founded. During the first session there were a few questions, but by the third 
session, everyone that this would be best practice for the clinical site.  
One limitation was the number of practitioners involved with the project. Four is 
relatively a low number; therefore, generalizability was not conclusive based on the full 
representation of workers at the clinic. There were more nurses and other physicians in 
the clinic as well as medical assistants who were not involved in the education on the use 
of the clinical guideline; only a select few were involved based on their experience. The 
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findings from the three sessions showed that the medical professionals involved 
understood the importance of statins and how they can help reduce heart disease. 
The findings implied that when this clinical practice guideline is fully 
implemented and in place at the site of the doctoral project that the nurse practitioners 
and physicians are willing to use it. As a matter of fact, discussion on implementation 
date was raised up by the primary stakeholder (the owner of the clinic) to the other 
medical professionals involved during the second session. The results reflected in this 
doctoral project demonstrate that opportunities remain for the use of clinical practice 
guidelines in primary care to help provide evidence-based practice to all patients at the 
site. During one of the expert panel sessions, a question was raised by one of the nurse 
practitioners regarding what should be done if the patient is not a candidate for statin 
therapy. An example that the nurse practitioner gave was that she had a patient that was a 
candidate for statins but could not tolerate statins in general. The patient experiences 
extreme joint pain and her creatine kinase levels become abnormally high. She asked, 
what are other options for patients like this one? I later explained to that nurse 
practitioner that what I do in this case scenario where a statin is not tolerated by the 
patient is that I offer fish oil. Depending on the LDL levels and triglyceride level I may 
also prescribe Gemfibrozil. I further explained to her that Gemfibrozil mainly targets the 
triglyceride level but also has some effect on the LDL level. All together everyone agreed 
to adopt the practice guideline. There were no additional questions besides the one. 
Proposed date for implementation was set for September 9, 2019. The implementation 
plan includes the need to provide thorough education for all the clinical staff members, 
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not just those who were included in the expert panel. Poster boards will be constructed to 
job specifications. For instance, the first board will map out intake process for the 
medical assistants. The next board will be for the nurse practitioners and physicians. Last 
board will discuss check out and the need for follow up. The education will take place 
different days to accommodate everyone at the practice.  
This doctoral project provides awareness on the under-prescription use of statins 
to those at risk for the prevention of heart disease at this doctoral site. This project 
allowed for a nurse practitioner led education to occur to other fellow nurse practitioners 
and physician involvement to create positive social change. Focusing on this practice 
problem within the practice will improve quality health outcomes for patients.  
Recommendations 
Based on the findings within this doctoral project, I recommend the 
implementation of this clinical practice guideline to help bring awareness to the issue and 
increase the prescription use of statins which in turn can decrease a patient’s chances of 
developing heart disease. This project contributed to addressing the gap in practice 
regarding under prescription use of statin therapy for the prevention of heart disease and 
the site lack of a clinical guideline in place to address the gap in practice. This clinical 
guideline will help improve patient care and increase the use of evidence-based care. As 
patients’ statuses may change a review of this clinical practice guideline may be needed.  
It is important to develop a quality improvement project over the next six months 
to determine the impact of the statin guideline. The quality improvement project should 
include the number of patients prescribed a statin every month for six months. If certain 
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patients were missed, then a case review of those patients should be reviewed and 
discussed.  
Strengths and Limitations 
The strength within this doctoral project was that it used an algorithm in order to 
address the need of primary care providers involvement as well as nurses and medical 
assistants. The algorithm is easy to follow and comes with a manual on how to use the 
practice guideline. Recommendations for future projects will address issues that may 
cause medication nonadherence and alternatives for patients who cannot tolerate statins. 
Another recommendation will be, to involve a larger amount of nurse practitioners, 
physicians and other medical personnel as well as provisions for patient feedback.  
My plan is to disseminate this work to both clinics in the practice since each had 
experienced the practice problem. The algorithm should be posted in all exam rooms and 
placed on clip boards of all medical assistants. Other clinical personnel such as the 
medical office manager should have those materials as well. It is then left for the stake 
holder to push implementation. Suggestions of quarterly chart audits was also 
recommended. Limitations was getting the staff together. This will also be a challenge 
during the time to educate other staff members before implementation of the guideline.  
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Section 5: Dissemination Plan 
Dissemination Plan 
The issue of underprescription of statins to help prevent heart disease for those 
patients at risk continues to be a problem in the healthcare setting. The findings and work 
from this project will be disseminated to provide awareness of this issue in primary care. 
Based on the nature of this project, the audiences and venues that will be appropriate for 
project dissemination consist of primary care providers (nurse practitioners, physicians, 
physician assistants) who are medically trained to diagnose. Registered nurses should be 
used as patient advocates who will alert the primary care providers when there is a need 
for statin therapy. This project is appropriate for an outpatient primary care setting as 
well as cardiology practices and even hospital inpatient units who discharge patients to 
home.  
Analysis of Self 
In this section, I provide an analysis of myself in the role of a nurse practitioner, 
scholar, and project manager. As a practitioner, I will address a practice area that has 
been underserved. In this practitioner role, I noticed that this project increased my 
awareness of the need to ensure evidence-based practice in primary care not only to 
promote statin use for the prevention of heart disease but also to promote preventive 
medicine. As a scholar, I found that this project gave me skills and insight I needed to 
render evidence-based practice to support positive health outcomes in the primary care 
sector. In the role of project manager, I fully understood the importance of 
interdisciplinary communication.  
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The completion of this project resulted in the support of the clinical practice 
guideline for implementation. The challenge was getting the expert panels together for 
the three sessions. The solution was for me to take time off work and to adapt to their 
schedules. To gain insights, I developed a PowerPoint presentation and open-ended 
questions for the expert panel.  
Summary 
Clinical practice guidelines are important to maintain continuity of quality care as 
it relates to statin therapy and the prevention of heart disease. This doctoral project 
sought to develop a clinical practice guideline that would promote the use of statins to 
help prevent heart disease, and approval from the expert panel for implementation was 
achieved. Implementation was not achieved and was not a part of this project but plans 
for implementation were discussed.  
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Appendix B: Statin use Clinical Guideline Curriculum 
Learning Outcome(s): NPs will properly prescribe statins as a preventive measure in the primary care setting.  
 
Topical Content Outline Time 
frame 
References Teaching method/learner 
engagement and 
Evaluation method 
What are statins 
 
Cholesterol lowering 
medications in patients at risk 
for developing coronary artery 
disease  
15 minutes Jones et al., 2016 PowerPoint 
CAD 
CAD is the buildup of plaque in 
the arteries of the heart which 
restricts the necessary blood 
flow to the heart). 
30 
minutes 
Gander et al., 2014 PowerPoint 
Question answer sessions 
How to use the clinical guideline 
In a primary care setting, a 
clinical guideline can be used to 
screen and identify those at risk 
for CAD and treat them with 
statin therapy to help prevent the 
development of coronary artery 
disease. 
A clinical guideline improves 
the quality of health and 
outcomes for patients with 
various diseases 
30 
minutes 
Lawal et al., 2006. Picture 
Case studies 
Questions 15 Minutes  Brief discussion with 
participants.  
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Appendix C: Tips for Using the Statin use Guideline in Primary Care 
Part I. The initial visit 
• It is important to gather important data such as patient’s medical history, family 
history, vital signs and physical assessment of the patient.  
• Next, routine labs should be collected with specific attention to hemoglobin A1c 
(HgA1c) level and low density lipoprotein (LDL). HgA1c is a blood test that 
measures glucose concentration over a three month period (Silva, Ana Paula, et al 
2013).  
• A two week follow up appointment will be given to the patient to review the 
patients’ results.  
Part II. Follow up visit 
The patient arrives for their two weeks follow up appointment.  
• If the LDL is greater than or equal to 190, statin therapy should be started. 
• If not then next we need to look to see if the HgA1c is greater than 6.4 or if the 
patient has already been diagnosed previously as a diabetic and LDL is 70-189. A 
statin should be considered if this is the case. 
• If LDL is low and patient is not a diabetic then the risk for cardiovascular disease 
should be calculated using QRISK3. The QRISK3 estimates a person’s risk for 
developing heart disease within the next ten years. The website where you can 
find the QRISK3 calculation is https://qrisk.org. Pending on patient’s individual 
QRISK scores will determine the need for statin to be initiated to those 
individuals with a normal LDL and HgA1c level.  
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Appendix D: Open-Ended Questions for Expert Panel 
Round 1:  
1. After hearing the presentation and reviewing the practice guideline for 
statin use in primary care, what are your immediate impressions?  
2. What barriers or obstacles do you see if you were to implement the 
practice guideline?  
3. What revisions would you like to see before implementation?  
Round 2:  
1. What concerns do you have about the implementation plan?  
2. How will you monitor and measure the impact of the practice guideline on 
care in the future?  
3. How will you know that the practice guideline is having an impact on 
preventive care at the primary care practice?  
Round 3:  
1. Do you have any additional concerns that you would like to see 
addressed? If so, please state them now. If not, process to the next 
question.  
2. Do you approve the practice guideline for full implementation?  
3. What start date do you recommend?  
